Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buschauer

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Archiv Der Pharmazie|August 1, 1992
The effect of lipophilic substituents on the H2-histaminergic activity of some close analogues of impromidineC Sellier, S Elz, A Buschauer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 1998
Combined histamine H1/H2 receptor antagonists: part II. Pharmacological hybrids with pheniramine- and tiotidine-like substructuresC Wolf, F R Schulze, A Buschauer, et al.
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonistsS Dove, M C Michel, S Knieps, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha)K Wenzel-Seifert, M T Kelley, A Buschauer, et al.
Molecular Pharmacology|August 1, 1992
Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogueR Seifert, A Höer, S Offermanns, et al.
Cancer Letters|December 5, 1998
Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteersI Muckenschnabel, G Bernhardt, T Spruss, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 1, 1995
Different activities of impromidine and related phenyl-(pyridylalkyl)guanidines at cardiac and gastric H2 receptorsG Coruzzi, M Adami, C Pozzoli, et al.
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cellsC Moser, G Bernhardt, J Michel, et al.
International Journal of Pharmaceutics|May 9, 2002
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenograftsW Vogelhuber, T Spruss, G Bernhardt, et al.
Archiv Der Pharmazie|July 1, 1994
[Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures]F R Schulze, R A Alisch, A Buschauer, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Archiv Der Pharmazie|August 1, 1992
The effect of lipophilic substituents on the H2-histaminergic activity of some close analogues of impromidineC Sellier, S Elz, A Buschauer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 1998
Combined histamine H1/H2 receptor antagonists: part II. Pharmacological hybrids with pheniramine- and tiotidine-like substructuresC Wolf, F R Schulze, A Buschauer, et al.
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonistsS Dove, M C Michel, S Knieps, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha)K Wenzel-Seifert, M T Kelley, A Buschauer, et al.
Molecular Pharmacology|August 1, 1992
Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogueR Seifert, A Höer, S Offermanns, et al.
Cancer Letters|December 5, 1998
Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteersI Muckenschnabel, G Bernhardt, T Spruss, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 1, 1995
Different activities of impromidine and related phenyl-(pyridylalkyl)guanidines at cardiac and gastric H2 receptorsG Coruzzi, M Adami, C Pozzoli, et al.
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cellsC Moser, G Bernhardt, J Michel, et al.
International Journal of Pharmaceutics|May 9, 2002
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenograftsW Vogelhuber, T Spruss, G Bernhardt, et al.
Archiv Der Pharmazie|July 1, 1994
[Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures]F R Schulze, R A Alisch, A Buschauer, et al.
Pageof 7